0001354457-15-000156.txt : 20150827
0001354457-15-000156.hdr.sgml : 20150827
20150827092630
ACCESSION NUMBER: 0001354457-15-000156
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20150827
DATE AS OF CHANGE: 20150827
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: RESPONSE GENETICS INC
CENTRAL INDEX KEY: 0001124608
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33509
BUSINESS ADDRESS:
STREET 1: 1640 MARENGO ST.,
STREET 2: 6TH FLOOR
CITY: LOS ANGELES,
STATE: CA
ZIP: 90033
BUSINESS PHONE: (323) 224-3900
MAIL ADDRESS:
STREET 1: 1640 MARENGO ST.,
STREET 2: 6TH FLOOR
CITY: LOS ANGELES,
STATE: CA
ZIP: 90033
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0001124608
RESPONSE GENETICS INC
001-33509
1640 Marengo Street, 7th Floor
Los Angeles
CA
CALIFORNIA
90033
323 224-3900
Common stock
17 CFR 240.12d2-2(b)
Amy Horton
Hearings Advisor
2015-08-27
EX-99.25
2
rgdxdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
August 27, 2015, Response Genetics, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Response Genetics, Inc.
(the Company), effective at the opening of the trading
session on September 8, 2015. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5550(a)(2) and 5550(b)(1).
The Company was notified of the Staffs
determination on December 19, 2014. The Company appealed
the determination to a Hearing Panel.
Upon review of the information provided by the Company,
the Panel issued a decision dated February 17, 2015, granting
the Company continued listing pursuant to an exception
that included several milestones that the Company was
required to meet, towards the toal of regaining compliance
with Listing Rules 5550(a)(2) and 5550(b)(1).
However, the Company was unable to meet the
exception milestones as required. On July 2, 2015,
the Panel issued a final delisting determination and
notified the Company that trading in the Companys
securities would be suspended on July 6, 2015.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company became
final on August 17, 2015.